Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-06

Clinical Trial Update: Evaluation of Outcomes Using the Amo Advanced CustomVue Ilasik Procedure

View source ↗

Summary

The clinical trial evaluating the Amo Advanced CustomVue Ilasik procedure for correcting myopia and hyperopia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Myopia, Hyperopia | Status: WITHDRAWN